Endolipid Therapeutics
1 known investors
Endolipid Therapeutics is a biotech developing SHBG-mimicking peptides aimed at reducing ectopic fat accumulation to treat conditions such as fatty liver disease and NASH, as well as cellulite. Its work spans therapeutic and dermocosmetic applications.
Founders & leadership
GD
Giacomo de SimoneCEO
DM
David M. SelvaCSO
RS
Rafael SimóCMO
AS
Agustí SolerCFO
Investors · 1
Frequently asked questions
- What does Endolipid Therapeutics do?
- Endolipid Therapeutics is a biotech developing SHBG-mimicking peptides aimed at reducing ectopic fat accumulation to treat conditions such as fatty liver disease and NASH, as well as cellulite. Its work spans therapeutic and dermocosmetic applications.
- Who are Endolipid Therapeutics's investors?
- Endolipid Therapeutics's investors include Capital Cell.